uptake, fluorometric Ca 2ϩ measurements and spectrophotometric ATPase assays were used. Ca 2ϩ uptake into SR vesicles was inhibited in a concentration-dependent manner when Br Ϫ or I Ϫ replaced extravesicular Cl Ϫ (when Br Ϫ completely replaced Cl Ϫ , uptake velocity was ϳ 70% of control; when I Ϫ completely replaced Cl Ϫ , uptake velocity was ϳ 39% of control). Replacement of Cl Ϫ with SO 4 2Ϫ had no effect on SR uptake. Although both I Ϫ and Br Ϫ inhibited net Ca 2ϩ uptake, neither anion directly inhibited the SR Ca 2ϩ pump nor did they increase the permeability of the SR membrane to Ca 2ϩ . Our results support the hypothesis that an anionic current that occurs during SR Ca 2ϩ uptake is reduced by the substitution of Br Ϫ or I Ϫ for Cl Ϫ .
sarcoplasmic reticulum vesicles; fura 2; ATPase activity; anion substitution THERE HAS BEEN A GREAT DEAL of interest recently in the effects of halides and other anions on the function of the sarcoplasmic reticulum (SR). It has been reported, for example, that some anions including Cl Ϫ and I Ϫ can increase the Ca 2ϩ permeability of the skeletal muscle ryanodine receptor over that measured in the presence of organic anions such as propionate Ϫ (2, 8, 25, 26, 29) . A Cl Ϫ -sensitive nonselective channel that allows Ca 2ϩ to permeate the SR membrane has also been postulated to exist in skeletal muscle (39) . Other investigators (37) suggested that the SR Ca 2ϩ pump itself can be directly inhibited by I Ϫ and SCN
Ϫ
. In addition to affecting these mechanisms, the anionic environment of the SR could also influence the movement of compensatory charge across the SR membrane during Ca 2ϩ uptake or release. That such movement occurs has been inferred primarily from the following two types of observations (reviewed in Refs. 3, 7, 22, 23, 30 , and 40): 1) although the Ca 2ϩ -ATPase of the SR of muscle cells is believed to be electrogenic, a sustained membrane potential has not been detected across the SR membrane; and 2) both anion and cation channels are found in SR membranes. Thus other ions are thought to cross the membrane to balance charge as Ca 2ϩ is released from the SR or actively transported into the SR. In support of this mechanism in smooth muscle, we (33) have shown that SR Ca 2ϩ uptake is inhibited in the presence of the Cl Ϫ channel inhibitors 5-nitro-2(3-phenylpropylamino)benzoic acid (NPPB) or indanyloxyacetic acid 94 [R(ϩ)-IAA-94] and by the substitution of SO 4 2Ϫ for Cl Ϫ in the medium outside the SR. In a recent work (14) , we have shown that cardiac SR Ca 2ϩ uptake is inhibited by the Cl Ϫ channel blocker tamoxifen. The latter effect occurs without an alteration in the ATPase activity of the SR Ca 2ϩ pump and without a significant change in the permeability of the SR membrane to Ca 2ϩ . In the work reported here, we studied Ca 2ϩ uptake into cardiac SR vesicles when I . This occurred without a detectable effect of I Ϫ or Br Ϫ on the ATPase activity of the SR Ca 2ϩ pump and without an increase in the Ca 2ϩ permeability of the SR membrane.
METHODS
Preparation of SR vesicles. Animals were euthanized with an overdose of pentobarbital sodium in accordance with procedures approved by the Canadian Council on Animal Care and the University of Calgary Faculty of Medicine Animal Care Committee. SR vesicles were prepared from canine ventricular tissue as previously described (15) according to the method of Chamberlain et al. (1) omitting the sucrose density gradient centrifugation step.
Measurement of SR Ca 2ϩ uptake. The fluorometric method for measuring Ca 2ϩ uptake into SR vesicles using fura 2 was described previously (15, 16, 18) . Briefly, SR vesicles were first diluted to a total protein concentration of 1 mg/ml in uptake buffer containing 100 mM KX (where X is Cl Ϫ , I Ϫ , or Br Ϫ ), 4 mM MgX 2 , and 20 mM HEPES (pH 7.0); or 50 mM K 2 SO 4 , 4 mM MgSO 4 , and 20 mM HEPES. Vesicle samples were then added to a 4-ml cuvette containing 2 ml of uptake buffer. For most experiments, oxalate was included in uptake buffer to act as a trapping ion for Ca 2ϩ within the SR (28). When oxalate was not included, a higher vesicle protein concentration and other adjustments to the uptake buffers were required to increase measurable SR Ca 2ϩ uptake. Differences in the uptake buffers that were used in experiments done in the presence and absence of oxalate are shown in Table 1 . When tetraethylammonium (TEA; 10 mM) was added to either KI or KCl uptake buffer, the K ϩ concentration of the buffers was reduced by 10 mM to maintain ionic strength. Uptake was initiated by the addition of Ca 2ϩ to the cuvette. Fluorescence was measured with a SPEX fluorimeter (CMX model; Edison, NJ). Fura 2 was excited at 340-and 380-nm wavelengths, and fluorescence emission was measured through a 510-nm band-pass filter (10-nm bandwidth). Fluorescence ratios (340-380 nm) were obtained every 1 s. , and instantaneous uptake velocity were determined from the fura 2 fluorescence ratio values after correction for background fluorescence and light scatter as described previously (9, (14) (15) (16) (17) (18) . [Ca 2ϩ ] total was determined from [Ca 2ϩ ] free as described previously (14-18) using published binding constants (4, 12, 27, 36) . The protein concentration of the vesicle preparations was determined by the Bradford protein assay (kit purchased from Bio-Rad; Hercules, CA). The maximum velocity of Ca 2ϩ uptake was determined from plots of uptake velocity versus [Ca 2ϩ ] free as described by Kargacin and Kargacin (15) . Oxalate is capable of crossing the SR membrane and acts as a Ca 2ϩ -precipitating anion within SR vesicles (28) . The advantages of using oxalate in uptake buffers are that it permits greater unidirectional Ca 2ϩ movement and prolongs the initial rapid phase of uptake (28) . This allows uptake to be determined from a single vesicle sample over the entire range of physiological [Ca 2ϩ ] free (15, 18) . As discussed below (see RESULTS), however, it was necessary to conduct some experiments in the absence of oxalate. Without oxalate acting as a trapping ion in the SR lumen, as uptake occurs, the free Ca 2ϩ gradient that develops across the vesicle membrane inhibits further uptake. This causes a decline in the rate of uptake to occur at free Ca 2ϩ levels that are higher than those required to define complete uptake velocity curves similar to those obtained in the presence of oxalate. Therefore, for experiments done without oxalate, velocity was determined from the slope of the steepest part of [Ca 2ϩ ] total versus time curves.
In either the presence or absence of oxalate, the rate of Ca 2ϩ uptake for a specific cardiac SR vesicle preparation is dependent on the purity of the preparation. For this reason, to allow experiments done with different vesicle preparations to be compared, uptake velocities are expressed as a percentage of the average control value (set at 100%) obtained in each experiment. The actual values for the uptake velocities of the control samples done in the presence of oxalate ranged from ϳ0.3 to ϳ0.7 mol ⅐ min Ϫ1 ⅐ mg Ϫ1 for the vesicle preparations used in the present study.
Measurement of SR Ca 2ϩ release. For Ca 2ϩ release experiments, the uptake buffers described above were used except that 5 mM D-glucose was included as a substrate for hexokinase and creatine phosphate (CP) and creatine phosphokinase (CPK) were omitted from the uptake buffer. After the SR was loaded and net Ca 2ϩ movement into the SR stopped, hexokinase (4.7 U/ml) was added to the cuvette to deplete the buffer of ATP to allow passive Ca 2ϩ release to be measured.
Measurement of ATPase activity of SR Ca
2ϩ pump using NADH fluorescence. An enzyme-coupled assay (19) 
where F is the fluorescence intensity in counts per second and a and b are constants. For SR vesicles, the change in NADH content in the sample was linear (see Fig. 5 ); the rate of change of NADH was therefore determined from linear regression for a 100-to 200-point (50-100 s) segment of the data. For the assay, the sample sizes ranged from 30-190 g vesicle protein depending on the SR vesicle preparation used.
To rule out the possibility that the ATPase assay itself was rate limiting, control experiments were done to show that doubling the amounts of pyruvate kinase and LDH in the assay did not change the Ca 2ϩ -ATPase rates measured by the assay. The ATPase activity of the preparation (when expressed as mol ⅐ min Ϫ1 ⅐ mg Ϫ1 vesicle protein) was also not altered when the amount of vesicle protein was doubled.
To determine whether substitution of Cl Ϫ with Br Ϫ or I Ϫ had a direct effect on the enzyme-coupled ATPase assay, NADH fluorescence changes (Fig. 1B) were measured by adding ADP to KCl, KBr, or KI buffers plus assay components but without ATP or SR vesicles present. The results of these experiments showed that Br Ϫ and to a greater extent I Ϫ inhibit the assay itself. As shown in Fig. 1C , the initial rate of change of NADH fluorescence in the ATPase assay in response to ADP addition was reduced to 65.2% of control in 
H1625
KBr buffer and to a greater extent (29.4% of control) in KI buffer. These results were used to correct the measurements of ATPase activity of the cardiac SR Ca 2ϩ pump.
Measurement of ATPase activity of SR Ca
2ϩ pump using purine-nucleoside phosphorylase. A second spectrophotometric assay (43, 44) in which the inorganic phosphate (P i ) generated by the ATPase activity of the SR Ca 2ϩ pump was measured was also used to determine whether substitution of I Ϫ for Cl Ϫ had a direct inhibitory effect on the SR Ca 2ϩ -ATPase. In the assay, purine-nucleoside phosphorylase (PNP) converts 2-amino-6-mercapto-7-methylpurine riboside (MESG) and P i to ribose 1-phosphate (R1-P) and 2-amino-6-mercapto-7-methypurine (AMM)
As the SR Ca 2ϩ pump hydrolyzes ATP and generates P i , conversion of MESG (maximum absorbance at 330 nm) to AMM (maximum absorbance at 360 nm) results in an absorbance increase at 360 nm that is proportional to the change in P i . The generation of P i by turnover of the cardiac SR Ca 2ϩ pump was measured in buffer containing 100 mM KX (where X is Cl or I), 4 mM MgX 2 , 1.1 mM ATP, 1 U/ml PNP, 150 M MESG, and 20 mM HEPES (pH 7.0; [Ca 2ϩ ] free Ϸ 3 M). 4-Br-A23187 (3.3 M) was included in the buffer for the reasons discussed above. Measurements were made in a 4-ml cuvette with an ultraviolet/visible spectrophotometer (model Lambda 3B, Perkin-Elmer; Norwalk, CT); solutions in the cuvette were continuously stirred during the experiments. The assay system was calibrated by adding known amounts of P i to the buffers. The calibration curves in Fig. 2A show that the magnitude of the change in absorbance for a given change in P i was slightly less in KI buffer than it was in KCl buffer. The rate at which the assay responded to step changes in P i was also compared in KCl and KI buffers. Figure 2B shows that the response of the assay to step changes in P i was slightly slower in the KI buffer. The mean initial rate of response in KI buffer (determined as shown in Fig. 2B ) for a variety of step changes and starting P i concentrations was 79.4 Ϯ 4.6% (n ϭ 7) of that measured in KCl buffer. Figure 2C shows that the rate at which the enzyme system could respond to changes in P i was not limited by the rate at which solutions could be stirred into the cuvette.
For the measurement of the ATPase activity of the SR Ca 2ϩ pump, all assay components except cardiac SR vesicles were first added to the buffer and the reaction described in Eq. 2 was allowed to proceed to remove contaminating P i in the buffer. Vesicles (30 g) were then added, and the additional P i generated by the SR Ca 2ϩ pump was determined as a function of time from the change in absorbance at 360 nm (measured at 1-s intervals) with the use of the calibrations shown in Fig. 2 . The slopes of the P i versus time curves (determined by a linear fit to the steepest linear part of the curve; typically 100 data points ϭ 100 s) were determined and used to compare the ATPase activity of the SR Ca 2ϩ pump in different solutions. Figure 2D shows a curve of P i versus time for an experiment with SR vesicles in KCl buffer.
Reagents. ADP (potassium salt), K 2 ATP, CP, CPK, NADH, phosphoenol pyruvate, pyruvate kinase, dithiothreitol, 4-aminopyridine, D-glucose, and histidine were purchased from Sigma Chemical (St. Louis, MO). Aristar grade KCl, KOH, and sucrose, Suprapur KI, and AnalaR KBr were purchased from BDH (Edmonton, AB, Canada). Hexokinase was purchased from Roche Diagnostics (Laval, QC, Canada). Microselect MgCl 2 ⅐ 6H 2 O and MgBr 2 ⅐ 6H 2 O, puriss grade oxalic acid and MgSO 4 ⅐ 7H 2 O, purum grade TEA hydroxide, and MgI 2 , ruthenium red, and HEPES (potassium salt) were purchased from Fluka (Ronkonkoma, NY). LDH was purchased from Worthington (Freehold, NJ). Fura 2 free acid, . Experiments were done in a 4-ml cuvette containing 2 ml of buffer containing the reagents for the assay (see text). The amount of NADH (in nmol) was determined from fluorescence using the calibration curves in A and the sample volumes in the cuvette. In these experiments, the maximum rates of response of the ATPase assay (solid lines) were determined from line fits to the first 100 data points (50 s; solid symbols) after the addition of ADP. The maximum rate of response of the assay to the addition of ADP in KI buffer was 31.3% of that measured in KCl buffer, indicating that I Ϫ inhibited the assay itself. Note: only every 4th data point is plotted for clarity. C: summary of results of experiments similar to that shown in B for KCl (n ϭ 12), KBr (n ϭ 6), and KI (n ϭ 6) buffers. Response rates, expressed as percentage of control, were 65.2% in KBr and 29.4% in KI and were significantly different from the rate in KCl (100%) at P ϭ 0.0009 and P ϭ 2.3 ϫ 10 Ϫ7 , respectively. Error bars are ϩ1 SD. http://ajpheart.physiology.org/ 4-Br-A23187, and the reagents for the purine-nucleoside phosphorylase assay (ENZCheck kit) were purchased from Molecular Probes (Eugene, OR). Experiments were carried out at 22°C. In RESULTS, errors are expressed as Ϯ1 SD.
RESULTS

Effect of anion substitutions on Ca
2ϩ uptake in SR vesicles in presence of oxalate. Substitution of K 2 SO 4 for KCl in the uptake buffer did not significantly change the rate at which Ca 2ϩ was taken up into the SR in the presence of oxalate. A comparison of uptake rates in K 2 SO 4 and KCl buffers is shown in Fig. 3A .
The uptake rate in KBr uptake buffer was less than that measured in KCl uptake buffer (Fig. 3B ) and was slower still in KI uptake buffer (Fig. 3C) . For the experiments shown, the maximum uptake rate was 71.9% of control in KBr and 44.4% of control in KI buffer. Consistent with the results shown in Fig. 3 , A-C, the results of several similar paired experiments showed that the maximum velocity was significantly 
rate of response of the assay after step changes in P i in KCl (circles) or KI (squares) buffer. Equal amounts of P i in H 2 O were added to a 4-ml cuvette containing 3.3 ml KCl or KI buffer and 137 M 2-amino-6-mercapto-7-methylpurine riboside (MESG), 1 U/ml purine-nucleoside phosphorylase (PNP), and 3.0 M 4-Br-A23187. P i as a function of time was determined from the calibration curves in A. The maximum rate of response (determined from line fits to the points shown by closed symbols) in KI buffer was 80.8% of that measured in KCl buffer. Note: data collected during the first 4 s (the time required for mixing; see C) after the addition of P i to the cuvette was not included in the calibration. C: time required for mixing. The time required for solutions added to the cuvette to mix was determined by adding fixed amounts of reaction product (2-amino-6-mercapto-7-methylpurine) to a cuvette containing 3 ml of KCl buffer. It required a mean time of 3.5 s for the assay system to completely respond to a step change in absorbance resulting from the addition of reaction product. D: generation of P i by the cardiac muscle sarcoplasmic reticulum (SR) vesicle preparation. P i generation (circles) was measured in a 4-ml cuvette containing 2 ml of KCl buffer, 30 g of SR vesicles, 3.3 M 4-Br-A23187, 150 M MESG, 1 U/ml PNP, and 1.5 mM ATP; free Ca 2ϩ concentration ([Ca 2ϩ ] free ) was ϳ3 M. The solid line is the line fit to a 100-point segment (F) of the data. The slope of the line (0.199 nmol P i /s) corresponds to an ATPase rate of 0.398
. Note: only every 4th data point is plotted for clarity. lower in KBr (69.8 Ϯ 4.6% in KBr, n ϭ 7; 100.0 Ϯ 7.8% in KCl, n ϭ 7) and KI (39.3 Ϯ 2.6% in KI, n ϭ 6; 100.0 Ϯ 13.4% in KCl, n ϭ 5) buffers. Uptake velocity was not significantly different from control in K 2 SO 4 buffer (94.4 Ϯ 8.8% in K 2 SO 4 , n ϭ 5; 100.0 Ϯ 13.4% in KCl, n ϭ 8). Figure 3D shows that the inhibitory effects of Br Ϫ and I Ϫ on uptake velocity were concentration dependent.
Inhibition of Ca 2ϩ uptake by I Ϫ in absence of oxalate. As noted above (see METHODS), measurement of SR Ca 2ϩ uptake in the presence of oxalate allows one to determine uptake rate for a single sample over a range of physiological [Ca 2ϩ ] free . However, although the relative concentration of oxalate to the other anions used in the experiments described above was low (10 mM oxalate:108 mM other anions), the presence of oxalate in the KBr and KI buffers may have partially masked the full inhibitory effect of these anions on Ca 2ϩ uptake. To test this possibility, the magnitude of the inhibitory effect of I Ϫ (the anion that inhibited SR uptake to the greatest extent) on Ca 2ϩ uptake was measured in the absence of oxalate. Figure 3E shows that in the ab- sence of oxalate, SR Ca 2ϩ uptake was still inhibited by I Ϫ to approximately the same extent as it was in the presence of oxalate (Fig. 3, C and D) . In experiments similar to those shown in Fig. 3E , the maximum rate of SR Ca 2ϩ uptake in KI buffer was 32.0 Ϯ 7.9% (n ϭ 6) of the maximum rate of uptake seen in KCl. This inhibitory effect of I Ϫ was not significantly different (P ϭ 0.11) from that measured in oxalate buffer, where the rate in KI buffer was 39.3 Ϯ 2.6% of the rate in KCl (n ϭ 6).
Inhibitory inhibited net SR Ca 2ϩ uptake in our experiments by increasing the permeability of the cardiac SR membrane through one of these mechanisms, one would expect ruthenium red to block this inhibition. Because the Ca 2ϩ sensitivity of the cardiac SR Ca 2ϩ -ATPase is reduced by ruthenium red (17) , Ca 2ϩ uptake measurements made in KI uptake buffer containing ruthenium red were compared with control experiments done in KCl buffer with the same concentration of ruthenium red. As shown in Fig. 4A , SR Ca 2ϩ uptake was reduced by I Ϫ even in the presence of ruthenium red. The extent of inhibition by I Ϫ was the same when ruthenium red (20 M) was present in the uptake buffers (summarized in Fig. 4B ) as it was in the absence of ruthenium red (mean uptake rate in KI with ruthenium red was 32.0 Ϯ 6.1% of the rate in KCl with ruthenium red; mean uptake rate in KI without ruthenium red was 39.3 Ϯ 2.6% of the rate in KCl buffer without ruthenium red).
Our results with ruthenium red show that the inhibitory action of I Ϫ on SR Ca 2ϩ uptake that was seen in our experiments cannot be explained by an I ; however, these authors did not discuss any effect of I Ϫ on the assay itself. Therefore, because we found that the rate at which the assay responded to fixed concentration of ADP was reduced in KBr buffer to 65.2% of the rate seen in KCl and, to a greater extent (29.4%), in KI buffer (see METHODS and Fig. 1) , we examined the ATPase activity of the cardiac SR Ca 2ϩ pump in the presence of Br Ϫ and I Ϫ and made corrections for the effects of these ions on the enzyme-coupled assay itself. Before correction for the direct inhibition of the assay by Br Ϫ , the maximum ATPase rate of the SR vesicles in KBr buffer was 72.9% of the maximum rate measured in KCl; before correction, the maximum rate in KI buffer was 38% of control (see Fig. 5B ). The apparent reductions in the rates in Br Ϫ and I Ϫ could be completely accounted for by the inhibitory effects of Br Ϫ and I Ϫ on the enzyme-coupled ATPase assay (Fig. 5, A and B) . Although the corrected results in Fig. 5B suggest that the ATPase rates in KBr and KI buffers may be somewhat faster than those measured in KCl buffer (significantly higher than those measured in KCl buffer at P ϭ 0.026 in KBr and P ϭ 0.034 in KI), the second ATPase assay (see below) indicates that this was probably not the case.
Because the rate of oxidation of NADH was reduced for the assay itself in the presence of Br Ϫ or I Ϫ (as shown in Fig. 1 27 .6% (range ϭ 5%) of the rate measured in its absence. In KI buffer, the inhibitory effect of 5 M thapsigargin on the measured ATPase rate was detectable and was 29.3 Ϯ 9.7% of the rate mea-sured in KI buffer without thapsigargin (n ϭ 4). In the presence of 10 M thapsigargin, the measured ATPase rate in KCl buffer was 20 Ϯ 8% (n ϭ 3) of that measured in its absence and was not significantly different from that measured in 5 M thapsigargin.
Because of the inhibitory effect of I Ϫ on the enzymecoupled assay utilizing pyruvate, pyruvate kinase, LDH, and NADH, a second method was also used to compare the ATPase activity of the cardiac SR Ca 2ϩ pump in KCl and KI buffers. The purine-nucleotide absorbance assay, described by Eq. 2 (see METHODS), was also affected by the presence of I Ϫ but to a far lesser extent than the first assay (compare Figs. 1 and  2 ). Figure 6 summarizes the results obtained with the absorbance assay and indicates that, after the correction of the results for the direct inhibition of the assay by I Ϫ , there were no differences in the ATPase rates of the SR Ca 2ϩ pump in KCl and KI buffers. The ATPase rates measured for vesicles from the same preparation in KCl buffer with this assay (0.398 mol P i ⅐ min Ϫ1 ⅐ mg Ϫ1 ; see Fig. 2 ) are in good agreement with those obtained using the NADH fluorescence assay (0.395
; see Fig. 5 ). The effect of thapsigargin on the ATPase activity of the SR Ca 2ϩ pump was also measured with the absorbance assay. As determined by the absorbance assay, 10.6 M thapsigargin reduced the measured ATPase activity of the vesicle preparation in KCl buffer to 26.1 Ϯ 2.3% (n ϭ 3) of control. This is in good agreement with the degree of inhibition (reduction to 20 Ϯ 8% of control in 10 M thapsigargin; see above) measured with the NADH fluorescence assay. ] free declined to 60 nM in the cuvette. Hexokinase was then added (at 335 s for KCl; 500 s for KI) to rapidly deplete the buffer of ATP, and the rates of the resulting Ca 2ϩ release were compared in the two buffers. D: Ca 2ϩ release segments from the curves in C are shown for KCl (E) and KI () aligned on the time axis for comparison. Release rates were determined by a linear regression fit to the first 100 points of the release curves. Release rates were 2.28 ϫ 10 Ϫ3 M/s in KCl (regression line shown by dashed line) and 1.86 ϫ 10 Ϫ3 M/s for KI (solid line). These rates, normalized to total protein, were 1.97 nmol ⅐ min Ϫ1 ⅐ mg Ϫ1 in KCl buffer and 1.61 nmol ⅐ min Ϫ1 ⅐ mg Ϫ1 in KI buffer.
SR uptake in presence of TEA or 4-aminopyridine. Although it has been suggested (see Refs. 22 and 23) that Cl Ϫ may be the primary ion involved in compensating for the net positive charge moved into the SR by the Ca 2ϩ -ATPase, movement of K ϩ out of the SR lumen may also occur and could become more important under conditions in which anion movement is inhibited to the greatest extent (i.e., KI buffer). To test the possibility that efflux of K ϩ out of the SR occurred during SR Ca 2ϩ uptake, uptake rates in KCl and KI buffers were compared in the presence and absence of 4-aminopyridine or TEA. These blockers were used because they are known to block skeletal muscle SR K ϩ channels from the cytoplasmic side of the SR membrane at the concentrations used in our experiments (6, 7) . Figure 7 shows that 1 mM 4-aminopyridine had no significant effect on the maximum rate of SR Ca 2ϩ uptake in KCl buffer or on the reduced uptake rate measured in KI buffer. The maximum rates of uptake in KCl or KI buffers were also unaffected by 10 mM TEA (results not shown). Table 2 summarizes the results of our study showing that, although the substitution of extravesicular Cl Ϫ with either Br Ϫ or I Ϫ inhibits Ca 2ϩ uptake into cardiac SR vesicles, neither ion has a direct inhibitory effect on the SR Ca 2ϩ pump nor does the inhibition of uptake appear to be accompanied by an increase in the Ca 2ϩ permeability of the SR membrane. As discussed below, our results are consistent with the hypothesis that the anionic environment of the SR can modulate Ca 2ϩ up- Ϫ on the ATPase assay are shown (solid symbols). The maximum rates of change in NADH for the raw data (red lines) were determined by line fits to the data segments between the yellow symbols. These slopes were Ϫ1.25 nmol/s in KCl buffer and Ϫ0.457 nmol/s in KI buffer. These values correspond to ATPase rates of 0.395 mol P i ⅐ min Ϫ1 ⅐ mg Ϫ1 in KCl and 0.144 mol P i ⅐ min Ϫ1 ⅐ mg Ϫ1 in KI buffer, respectively. The maximum uncorrected rate of change in NADH in KI was 36.8% of that measured in KCl buffer; this difference in rate could be entirely accounted for by the inhibition of the ATPase assay itself by I Ϫ (response of the assay in KI buffer to a step change in ADP was reduced to 29.4 Ϯ 9.8% of control; see (2, 8, 25, 26, 29, 31, 39) ; however, similar effects on the cardiac muscle ryanodine receptor have not been consistently observed (8, 25) . It has also been proposed (39) that a nonselective channel mediates a Cl Ϫ -induced increase in Ca 2ϩ permeability in skeletal muscle SR. This permeability increase was not seen with I Ϫ or Br Ϫ (39). The aniondependent increases in Ca 2ϩ release from skeletal muscle SR, whether mediated through the ryanodine receptor or through a Cl Ϫ -sensitive nonselective channel (39) , have been shown to be blocked by ruthenium red (see Refs. 26 and 39). In our experiments, the inhibition of SR uptake by the substitution of I Ϫ for Cl Ϫ was the same in the presence and absence of ruthenium red (Table 2 and Fig. 4 ). This is inconsistent with the hypothesis that inhibitory effects I Ϫ and Br Ϫ on net Ca 2ϩ uptake are due to an increased Ca 2ϩ efflux through an SR Ca 2ϩ channel similar to those discussed above. We also showed (Table 2 and Fig. 4 (11), who measured the ATPase activity of the skeletal muscle SR Ca 2ϩ pump in the presence of I Ϫ (at concentrations as high as 40 mM) with the use of molybdate to monitor phosphate release. On the other hand, as noted above (see RE-SULTS), Stefanova et al. (37) reported an inhibition of the skeletal muscle SR Ca 2ϩ -ATPase by I Ϫ when ATPase activity was monitored with the same enzymecoupled ATPase assay (based on NADH fluorescence) that was used in some of our experiments. Although there may be differences in the influence of I Ϫ on the activity of the skeletal and cardiac SR Ca 2ϩ pumps, we believe that the discrepancy between the results of Highsmith (11) and those of Stefanova et al. (37) and between those of the latter authors and our own results can be accounted for by the effect of I Ϫ on the NADHbased assay itself. . To our knowledge, this type of uncoupling has not been reported for any known direct inhibitors of SR Ca 2ϩ pumps. Our previous work (33) showing that the rate of Ca 2ϩ uptake into the SR of smooth muscle is -ATPase. The conclusion that such an anion influx occurs during cardiac SR Ca 2ϩ uptake is also consistent with our recent work (14) showing that tamoxifen, an agent known to block some types of Cl Ϫ channels, inhibits cardiac SR uptake without directly inhibiting the SR Ca 2ϩ pump and without inducing a significant increase in the permeability of the SR membrane to Ca 2ϩ .
DISCUSSION
The fact that Br
Ϫ and I Ϫ have no effect on smooth muscle SR Ca 2ϩ transport suggests that the anionpermeant pathways in the SR are different in the two muscle types. This conclusion is consistent with our findings (33) that SR Ca 2ϩ uptake in smooth muscle is inhibited by two Cl Ϫ channel blockers [NPPB and R(ϩ)-IAA-94] that have no effect on cardiac muscle Ca 2ϩ uptake. We did not see effects of TEA (at a concentration high enough to block many types of K ϩ channels) or of 4-aminopyridine on Ca 2ϩ uptake in KI or KCl uptake buffers. If K ϩ movement significantly contributed to charge compensation during SR Ca 2ϩ uptake, we might have expected the K ϩ channel blockers to inhibit uptake. The results with TEA and 4-aminopyridine are generally consistent with those of Fink and Stephenson (6; see also Ref. 7) who found that the amount of force that could be produced by Ca 2ϩ released from the SR of skinned amphibian skeletal muscle fibers was not decreased but instead increased slightly when the SR was loaded in the presence of TEA (10 mm), 4-aminopyridine (6 M-2 mM), or other K ϩ channel blockers. Although our results cannot be used to completely rule out the involvement of a K ϩ -permeant pathway in the cardiac SR membrane that allows cations to leave the SR during Ca 2ϩ uptake, they do indicate that if cation movement does occur during uptake, it occurs through a channel or channels that are TEA and 4-aminopyridine insensitive. It is important to note in this regard that canine cardiac SR K ϩ channels reconstituted into lipid bilayers were found to be insensitive to pharmacological manipulation by lemakalim, glyburide, and charybdotoxin (32) . It is also possible that the involvement of K ϩ channels during uptake is more complex than would be expected for a channel that simply allowed K ϩ efflux from the SR (discussed in Refs. 6 and 7). Our results do not address the possibility that K ϩ movement is important during SR Ca 2ϩ release.
Comparison of the properties of the striated muscle SR anion channels that have been studied in isolation with the functional evidence from our study suggests some possible candidates for the channel(s) that mediates anion movement during SR Ca 2ϩ uptake. uptake, a functional property that is consistent with the involvement of a channel with properties similar to those of the small conductance Cl Ϫ channel identified by Kourie et al. (23) in rabbit skeletal muscle SR. To our knowledge, the permeability of this channel to Br Ϫ or I Ϫ has not been determined. In attempting to correlate single-channel studies with functional studies of the intact SR, one must also consider the possibility that different Cl Ϫ channels may function during SR Ca 2ϩ uptake and release or that more than one anion channel type is involved in either or both of these processes in the intact SR. If the latter possibility is the case, the properties of the Cl Ϫ -permeant pathway that can be deduced from measurements of net Ca 2ϩ uptake or release would be a composite of those of two or more channels. The relative importance of these channels during Ca 2ϩ uptake may depend on the anionic environment of the SR and/or the involvement of other SR membrane proteins or intracellular agents (see Refs. 21, 22, and 35, for example). The continued study of both the electrophysiological and molecular properties of specific anion channels isolated from SR membranes and studies such as ours, in which the net effects of various ions or molecules on SR function are examined, should help distinguish among these possibilities.
